These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1233253

  • 1. On the fate of furosemide in man.
    Beermann B, Dalén E, Lindström B, Rosén A.
    Eur J Clin Pharmacol; 1975 Oct 10; 9(1):51-61. PubMed ID: 1233253
    [Abstract] [Full Text] [Related]

  • 2. Biotransformation of furosemide in kidney transplant patients.
    Smith DE, Benet LZ.
    Eur J Clin Pharmacol; 1983 Oct 10; 24(6):787-90. PubMed ID: 6350024
    [Abstract] [Full Text] [Related]

  • 3. Elimination of furosemide in healthy subjects and in those with renal failure.
    Beermann B, Dalén E, Lindström B.
    Clin Pharmacol Ther; 1977 Jul 10; 22(1):70-8. PubMed ID: 872498
    [Abstract] [Full Text] [Related]

  • 4. On the absorption and metabolism of 35S-ampicillin.
    Swahn A.
    Eur J Clin Pharmacol; 1975 Dec 19; 9(2-3):117-24. PubMed ID: 1233260
    [Abstract] [Full Text] [Related]

  • 5. Biotransformation of furosemide in patients with acute pulmonary edema.
    Perez J, Sitar DS, Ogilvie RI.
    Drug Metab Dispos; 1979 Dec 19; 7(6):383-7. PubMed ID: 43224
    [Abstract] [Full Text] [Related]

  • 6. Bioavailability and diuretic effect of furosemide during long-term treatment of chronic respiratory failure.
    Ogata H, Kawatsu Y, Maruyama Y, Machida K, Haga T.
    Eur J Clin Pharmacol; 1985 Dec 19; 28(1):53-9. PubMed ID: 3987786
    [Abstract] [Full Text] [Related]

  • 7. Studies on the metabolism of meptazinol, a new analgesic drug.
    Franklin RA, Aldridge A.
    Br J Clin Pharmacol; 1976 Jun 19; 3(3):497-502. PubMed ID: 973975
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis.
    Hammarlund MM, Paalzow LK, Odlind B.
    Eur J Clin Pharmacol; 1984 Jun 19; 26(2):197-207. PubMed ID: 6723758
    [Abstract] [Full Text] [Related]

  • 9. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.
    Smith DE, Lin ET, Benet LZ.
    Drug Metab Dispos; 1980 Jun 19; 8(5):337-42. PubMed ID: 6107232
    [Abstract] [Full Text] [Related]

  • 10. Absorption, distribution, metabolism, and excretion of furosemide in dogs and monkeys I: analytical methodology, metabolism, and urinary excretion.
    Yakatan GJ, Maness DD, Scholler J, Novick WJ, Doluisio JT.
    J Pharm Sci; 1976 Oct 19; 65(10):1456-60. PubMed ID: 824434
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of furosemide in patients with congestive heart failure.
    Greither A, Goldman S, Edelen JS, Benet LZ, Cohn K.
    Pharmacology; 1979 Oct 19; 19(3):121-31. PubMed ID: 523503
    [Abstract] [Full Text] [Related]

  • 13. Furosemide kinetics in renal failure.
    Tilstone WJ, Fine A.
    Clin Pharmacol Ther; 1978 Jun 19; 23(6):644-50. PubMed ID: 648078
    [Abstract] [Full Text] [Related]

  • 14. Effect of cimetidine on the absorption and efficacy of orally administered furosemide.
    Rogers HJ, Morrison P, House FR, Bradbrook ID.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan 19; 20(1):8-11. PubMed ID: 7056605
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.
    Lee MG, Chiou WL.
    J Pharmacokinet Biopharm; 1983 Dec 19; 11(6):623-40. PubMed ID: 6678312
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
    Prandota J.
    Pediatr Res; 1983 Feb 19; 17(2):141-7. PubMed ID: 6828331
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of orally administered furosemide.
    Kelly MR, Cutler RE, Forrey AW, Kimpel BM.
    Clin Pharmacol Ther; 1974 Feb 19; 15(2):178-86. PubMed ID: 4812154
    [No Abstract] [Full Text] [Related]

  • 19. Implications of intraindividual variability in bioavailability studies of furosemide.
    Grahnén A, Hammarlund M, Lundqvist T.
    Eur J Clin Pharmacol; 1984 Feb 19; 27(5):595-602. PubMed ID: 6519165
    [Abstract] [Full Text] [Related]

  • 20. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ, Maness DD, Scholler J, Johnston JT, Novick WJ, Doluisio JT.
    Res Commun Chem Pathol Pharmacol; 1979 Jun 19; 24(3):465-82. PubMed ID: 109903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.